Literature DB >> 25752993

Burden of focal cryoablation versus brachytherapy versus active surveillance in the treatment of very low-risk prostate cancer: a preliminary head-to-head comprehensive assessment.

M A de Cerqueira1,2, W W Laranja2, B C F Sanches2, C R Monti3, L O Reis2,4.   

Abstract

Focal cryoablation (FC), brachytherapy (B) and active surveillance (AS) were offered to patients diagnosed with very low-risk prostate cancer (VLRPC) in an equal access protocol. Comprehensive validated self-report questionnaires accessed patients' erectile (IIEF-5) and voiding (IPSS) functions, Beck scales measured anxiety (BAI), hopelessness (BHS) and depression (BDI), SF-36 reflected patients' quality of life added to the emotional thermometers including five visual analogue scales (distress, anxiety, depression, anger and need for help). Kruskal-Wallis or ANOVA tests and Spearman's correlations were obtained among groups and studied variables. Thirty patients were included, median follow-up 18 months (15-21). Those on AS (n = 11) were older, presented higher hopelessness (BHS) and lower general health perceptions (SF-36) scores than patients opting for FC (n = 10) and B (n = 9), P = 0.0014, P = 0.0268 and P = 0.0168 respectively. Patients on B had higher IPSS scores compared to those under FC and AC, P = 0.0223. For all 30 included patients, Spearman's correlation (rs ) was very strong between BHS and general health perceptions (rs  = -0.800, P < 0.0001), and weak/moderate between age and BHS (rs  = 0.405, P = 0.026) and age and general health perceptions (rs  = -0.564, P = 0.001). The sample power was >60%. To be considered in patients' counselling and care, current study supports the hypothesis that even VLRPC when untreated undermines psychosocial domains.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  health; impact; instruments; load; low toxicity; minimally invasive; prostate cancer; psychological; psychometric; psychosocial; quality of life; questionnaires; self-report; survey; treatment

Mesh:

Substances:

Year:  2015        PMID: 25752993     DOI: 10.1111/ecc.12307

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  5 in total

1.  T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation.

Authors:  Michael A Cerqueira; Karen L Ferrari; Amilcar C de Mattos; Carlos R Monti; Leonardo Oliveira Reis
Journal:  World J Urol       Date:  2019-07-01       Impact factor: 4.226

2.  PSA nadir predicts biochemical recurrence after external beam radiation therapy combined to high dose rate brachytherapy in the treatment of prostate cancer.

Authors:  Marcos Os Coelho; Luciana Sb Dal Col; Diego M Capibaribe; Carla M Salgado; Thiago C Travassos; Vanderlei J Junior; Carlos R Monti; Leonardo O Reis
Journal:  Am J Clin Exp Urol       Date:  2022-02-15

3.  The Mind: Focal Cryotherapy in Low-Risk Prostate Cancer: Are We Treating the Cancer or the Mind?

Authors:  Leonardo de Oliveira Reis; H Ballentine Carter
Journal:  Int Braz J Urol       Date:  2015 Jan-Feb       Impact factor: 1.541

4.  The Biopsychosocial Burden of Prostate Biopsy at the Time of Its Indication, Procedure, and Pathological Report.

Authors:  Walker W Laranja; Brunno C F Sanches; Brunno R I Voris; João C C Alonso; Fabiano A Simões; Ronald F Rejowski; Leonardo O Reis
Journal:  Prostate Cancer       Date:  2019-04-01

Review 5.  Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers.

Authors:  John Panzone; Timothy Byler; Gennady Bratslavsky; Hanan Goldberg
Journal:  Cancers (Basel)       Date:  2022-03-17       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.